Abstract:The codrug efficacy increase approach is developed to improve the biopharmaceutical properties of the conventional antitumor drug 5-fluorouracil (Fu) through molecular salification by tapping the potential of biguanide agents in property optimization and further antitumor synergism. In this route, the biguanide phenformin (Phf) is noncovalently bonded with Fu through a proton transference procedure based on its acidic-alkalinity differences, thereby improving the physicochemical and pharmacokinetic behaviors of Fu and ultimately achieving enhanced efficacy by leveraging the synergized antitumor effect of Phf. Oriented by this, a novel codrug molecular salt, phenforminium 5-fluorouracilate (Fu-Phf), is assembled and systematically characterized for its precise structure employing single-crystal/powder X-ray diffraction and other analytical methods. The results revealed the presence of robust charge-assisted hydrogen bonds in the asymmetric unit, with its structural characteristics being internally hydrophilic and externally hydrophobic, which affects its in vitro physicochemical performances. Thereinto, the dissolubility and permeability of Fu are proven to be simultaneously improved after forming the molecular salt, which aligns positively with a series of theoretical predictions, including molecular electrostatic potential (MEP), reduced density gradient (RDG), frontier molecular orbitals (FMOs), and topological analysis based on the theory of atoms in molecules (AIMs). All of these result in improved in vivo pharmacokinetic performances of the molecular salt, leading to higher bioavailability over Fu alone. Encouragingly, the strengthened tumor inhibition properties of the Fu-Phf codrug are theoretically simulated through the molecular docking method and experimentally observed against selected cancer cell strains, showing significantly reduced IC50. Furthermore, the calculated CI values of less than 1.0 highlight the achievement of the synergistic effects of the two components in the codrug molecular salt. Consequently, this work introduces a fresh salification case of Fu, presenting promising potential for future development; simultaneously, it also provides insights into exploring the possibilities of biguanide medicine as antitumor reinforcement through dual-drug synergy and optimization strategies.

Solid state and solubility study of a potential anticancer drug-drug molecular salt of diclofenac and metformin

Metforminium 5-Fluorouracilate: the First Codrug Molecular Salt of 5-Fluorouracil Demonstrating Perfected in Vitro/vivo Characteristics and Synergic Antitumor Effects

Metformin-Mediated Improvement in Solubility, Stability, and Permeability of Nonsteroidal Anti-Inflammatory Drugs

Metformin-NSAIDs Molecular Salts: A Path towards Enhanced Oral Bioavailability and Stability

Nanomedicine-based Disulfiram and Metal Ion Co-Delivery Strategies for Cancer Treatment

A New Strategy to Design Isostructural Salts: the Case of the Antitumor Drug Dimethylaminomicheliolide

Salt Cocrystal of Diclofenac Sodium-L-Proline: Structural, Pseudopolymorphism, and Pharmaceutics Performance Study

The molecular salt of pyrimethamine and fenbufen for enhancing dissolubility via an assisted efficacy-increasing approach of dual-drug salt formation: A combined study including theory analysis and experiment validation

Integrating Theory with Experimental Studies on the Directed Assembly of Phenforminium 5-Fluorouracilate Toward Enhanced in Vitro/Vivo Properties and Synergistic Antitumor Efficacy

A Metformin-Ferulic Acid Salt with Improved Biopharmaceutical Parameters

Towards Understanding the Structure, Dynamics and Bio-activity of Diabetic Drug Metformin

Development of o-aminobenzamide salt derivatives for improving water solubility and anti-undifferentiated gastric cancer

Novel drug-drug salt crystals of metformin with ibuprofen or naproxen: Improved solubility, dissolution rate, and synergistic antinociceptive effects

A novel drug-drug cocrystal of tegafur and myricetin: optimized properties of dissolution and tabletability

Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake.

Stable Cocrystals and Salts of the Antineoplastic Drug Apatinib with Improved Solubility in Aqueous Solution

Preparation of disulfiram-Cu 2+ -polylactide nanofibrous membranes via electrostatic spinning and evaluation of their in vitro anticancer effects

A Crystalline Solid Adduct of Sulfathiazole-Amantadine: the First Dual-Drug Molecular Salt Containing Both Antiviral and Antibacterial Ingredients

Synergetic Effect of β-Cyclodextrin and Its Simple Carbohydrate Substituents on Complexation of Folic Acid and Its Structural Analog Methotrexate

Exploring Disulfiram's Anticancer Potential: PLGA Nano-Carriers for Prolonged Drug Delivery and Potential Improved Therapeutic Efficacy

Molecular docking of anti-inflammatory drug diclofenac with metabolic targets: Potential applications in cancer therapeutics